Photo of Jennifer S. Temel, MD

Jennifer S. Temel, MD

  • Clinical Director of Thoracic Oncology
  • Director, Cancer Outcomes Research Program
  • Professor of Medicine at Harvard Medical School

617-724-4000

Accepting New Patients

Overview

Departments

Hematology/Oncology

Medicine

Centers & Specialties

Cancer Center

Clinical Interests
  • Lung cancer
  • Esophageal cancer
  • Symptom management and quality of life
Medical Education
  • MD, Washington University School of Medicine in St. Louis
  • Residency, Brigham and Women's Hospital
  • Fellowship, Dana Farber Cancer Institute
Board Certifications
  • Medical Oncology
Locations
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • AllWays Health (NHP) - ACD
  • AllWays Health (NHP) - PBO
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Adult
Provider Gender
Female

Biography

Jennifer Temel MD is a Professor of Medicine at Harvard Medical School, Clinical Director of Thoracic Oncology at the Massachusetts General Hospital, Director of Cancer Outcomes Research at the Massachusetts General Hospital Cancer Center, and co-leader of the Dana Farber/Harvard Cancer Center Outcomes Research Program. Dr. Temel’s research focuses on optimizing palliative and supportive care for patients with cancer and their families. Her major research interest includes the study of early, integrated palliative care for patients with advanced cancers.

Research & Publications

Research Summary

Dr. Temel’s research focuses on palliative care, symptom management, and patient-clinician communication. She has studied novel care models of providing palliative care to patients with advanced cancer, including the early involvement of palliative care in the ambulatory care setting. Dr. Temel’s paradigm changing research in this area was published in the New England Journal of Medicine and the Journal of Clinical Oncology. As a thoracic oncologist, she has a longstanding interest in improving both physical and psychological symptom in patients with lung and esophageal cancer. She has conducted numerous trials aimed at improving physical function, fatigue, quality of life, mood, and shortness of breath in patients with advanced cancer.

Dr. Temel is also interested in enhancing patient-clinician communication about the goals of cancer treatment and patients’ preferences for care at the end of life. She has conducted several trials focused on improving patients’ understanding of their prognosis and patient-clinician communication about end of life care.

Her future goals are to continue to develop innovative interventions to improve communication between patients and their families and their oncology clinicians. Dr. Temel is also interested in mentoring students, trainees, and junior faculty and has two National Cancer Institute grants to support her efforts training others in palliative care and supportive care research.

Publications

View my most recent publications at PubMed

News & Events

  • Palliative care improves quality of life in cancer patients receiving bone marrow transplants

    Massachusetts General Hospital investigators have shown that integrating palliative care into the treatment of patients undergoing bone marrow transplantation for cancers like leukemia and lymphoma can improve their quality of life, relieve symptoms associated with the procedure, and reduce depression and anxiety in patients while also benefiting their caregivers.

  • Palliative care

    MGH Hotline 08.27.10 Integrating palliative care early in the treatment of advanced lung cancer not only improved patients' mood and quality of life, but also extended their lives.

  • Lung cancer patients receiving palliative care had improved quality of life, extended survival

    Integrating palliative care early in the treatment of patients with advanced lung cancer not only improved their mood and quality of life, it also extended their lives.

  • The fight against lung cancer lights up

    MGH Hotline 12/5/08 Prudential Tower Hundreds of individuals supporting the fight against lung cancer joined special guests from the MGH, the Massachusetts chapter of the Lung Cancer Alliance, WCVB-TV’s Heather Unruh, and state public health and public policy leaders for a touching candlelight vigil at the Prudential Center Courtyard Nov. 20.

Contact

Hematology/Oncology
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Fax: 617-724-1135

Back to Top